NVO - EMA to discuss possible link between GLP-1s suicidal thoughts: report
2024-04-08 15:11:44 ET
More on Eli Lilly, Novo Nordisk, etc.
- Eli Lilly: Three Threats To Its Huge Rally
- Why Eli Lilly And Rival Novo Nordisk Won't Be Troubled By Viking's Latest Weight Loss Data
- Eli Lilly: Diabetes And Weight Management Treatments Are The Winning Tickets
- Lilly to record $111M pre-tax IPR&D charges in Q1
- Zepbound shortage: Eli Lilly's weight-loss drug in limited availability through April-end